Page last updated: 2024-08-17

prednisone and 10-propargyl-10-deazaaminopterin

prednisone has been researched along with 10-propargyl-10-deazaaminopterin in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (37.50)	29.6817
2010's	4 (50.00)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Berthelot, CN; Duvic, M; Jones, D; Leitenberger, JJ; McLaughlin, P; Polder, KD; Pro, B	1
Link, BK; Rosenstein, LJ	1
Grossman, ME; Husain, S; MacGregor-Cortelli, B; Marneros, AG; Neylon, E; Nuovo, GJ; O'Connor, OA; Patterson, M; Silvers, DN; Zain, JM	1
Advani, RH; Ansell, SM; Beaven, AW; Carson, KR; Evens, AM; Foss, F; Horwitz, S; Lechowicz, MJ; Loberiza, F; Pinter-Brown, LC; Pro, B; Savage, KJ; Shustov, AR; Smith, SM; Vose, JM	1
Kaur, H; Lee, YS; Ong, SY; Phipps, C; Tan, L	1
Cairo, MS; Dhir, A; Hill, B; Waite, ES; Xavier, AC	1

Reviews

2 review(s) available for prednisone and 10-propargyl-10-deazaaminopterin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Optimizing chemotherapeutic strategies for peripheral T-cell lymphomas. Clinical lymphoma & myeloma, 2008, Volume: 8 Suppl 5 Topics: Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Delivery Systems; Humans; Lymphoma, T-Cell, Peripheral; Prednisone; Vincristine	2008

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Optimizing chemotherapeutic strategies for peripheral T-cell lymphomas.

Clinical lymphoma & myeloma, 2008, Volume: 8 Suppl 5

Topics: Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Delivery Systems; Humans; Lymphoma, T-Cell, Peripheral; Prednisone; Vincristine

2008

Trials

2 trial(s) available for prednisone and 10-propargyl-10-deazaaminopterin

Article	Year
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial. Clinical advances in hematology & oncology : H&O, 2014, Volume: 12, Issue:2 Suppl 5 Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Vincristine	2014
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial. British journal of haematology, 2016, Volume: 172, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine	2016

Article

Year

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): preliminary results from the T-Cell Consortium trial.

Clinical advances in hematology & oncology : H&O, 2014, Volume: 12, Issue:2 Suppl 5

Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Vincristine

2014

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.

British journal of haematology, 2016, Volume: 172, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine

2016

Other Studies

4 other study(ies) available for prednisone and 10-propargyl-10-deazaaminopterin

Article	Year
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate. Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:3 Topics: Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; CD4 Antigens; CD56 Antigen; Cyclophosphamide; Dendritic Cells; Doxorubicin; Drug Therapy, Combination; Female; Folic Acid; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Skin Neoplasms; Treatment Outcome; Vincristine; Vitamin B 12	2008
Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia causing skin erosions. Blood, 2009, Jun-18, Volume: 113, Issue:25 Topics: Adult; Aminopterin; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biopsy; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Doxorubicin; Drug Eruptions; Epidermis; Etoposide; Exanthema; Folic Acid Antagonists; Humans; Interferon alpha-2; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Prednisone; Recombinant Proteins; Vincristine; Zidovudine	2009
Pralatrexate Induces Long-Term Remission in Relapsed Subcutaneous Panniculitis-Like T-Cell Lymphoma. Annals of the Academy of Medicine, Singapore, 2019, Volume: 48, Issue:9 Topics: Adult; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cisplatin; Cyclophosphamide; Deoxycytidine; Dexamethasone; Doxorubicin; Folic Acid Antagonists; Gemcitabine; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma, T-Cell, Peripheral; Male; Neoplasm Recurrence, Local; Panniculitis; Prednisone; Remission Induction; Subcutaneous Fat, Abdominal; Vincristine	2019
Pralatrexate-based therapy induced response in an adolescent with refractory hepatosplenic T-cell lymphoma. Pediatric blood & cancer, 2020, Volume: 67, Issue:11 Topics: Adolescent; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Liver Neoplasms; Lymphoma, T-Cell; Prednisone; Prognosis; Splenic Neoplasms	2020